Status:
COMPLETED
Platelet Indices in Prediction of Mortality in Critically Ill Septic Patients
Lead Sponsor:
Amany Faheem
Conditions:
Platelet Indices
Mortality
Eligibility:
All Genders
18-65 years
Brief Summary
Platelets (PLT), a major and essential constituent of blood, plays an important role in physiological and pathological processes such as coagulation, thrombosis, inflammation and maintenance of vascul...
Detailed Description
Blood will be drawn from the peripheral vein, arterial or a central catheter for evaluation of whole blood count, C-reactive protein (CRP), and procalcitonin serum levels. This procedure will be done ...
Eligibility Criteria
Inclusion
- patients aged 18-65 years ICU stay more than 24 hours septic patients according to Third International Consensus Definitions Septic Shock patients according to Third International Consensus Definitions
Exclusion
- Pregnant women
- Patients with active hemorrhage
- Patients with hematological diseases (including anemia, hypersplenism
- Lymphoma or leukemia
- Rheumatism, and bone marrow diseases)
- Patients who had infused with blood or platelets prior to their admission
- Patients who had used anti-platelet drugs prior to their admission
- Patients who had received radiotherapy or chemotherapy or bone marrow transplantation 1 month prior to admission.
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 30 2020
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT04335955
Start Date
May 1 2020
End Date
November 30 2020
Last Update
November 24 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Amany Afheem
Tanta, Egypt